TELMISARTAN | A202397 | MYLAN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.1563
per ea
Lowest NADAC/Unit
$0.1039
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00378292277TELMISARTAN 80 MG TABLET | $0.1563 | EA | Generic | — | 2026-08-19 |
| 00378292293TELMISARTAN 80 MG TABLET | $0.1563 | EA | Generic | — | 2026-08-19 |
| 00378292177TELMISARTAN 40 MG TABLET | $0.1536 | EA | Generic | — | 2026-08-19 |
| 00378292193TELMISARTAN 40 MG TABLET | $0.1536 | EA | Generic | — | 2026-08-19 |
| 00378292077TELMISARTAN 20 MG TABLET | $0.1039 | EA | Generic | — | 2026-08-19 |
| 00378292093TELMISARTAN 20 MG TABLET | $0.1039 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.